Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Plos One|August 11, 2011
3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 ratsFay Lin Khong, Yuan Zhang, Amanda J Edgley, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 14, 2012
Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathyAkira Mima, Munehiro Kitada, Pedro Geraldes, et al.
Circulation Research|September 1, 2017
Regulation of Macrophage Apoptosis and Atherosclerosis by Lipid-Induced PKCδ Isoform ActivationQian Li, Kyoungmin Park, Yu Xia, et al.
Nature Communications|September 29, 2019
Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetesQian Li, Jialin Fu, Yu Xia, et al.
Diabetologia|December 10, 2016
SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetesWeier Qi, Qian Li, Chong Wee Liew, et al.
British Journal of Pharmacology|October 21, 2010
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerationsDoan Tm Ngo, Irene Stafford, Aaron L Sverdlov, et al.
The Journal of Clinical Investigation|January 26, 2016
PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblastsMogher Khamaisi, Sayaka Katagiri, Hillary Keenan, et al.
Investigative Ophthalmology & Visual Science|December 1, 2012
Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetesAkira Mima, Weier Qi, Junko Hiraoka-Yamomoto, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2009
Expression, localization, and function of the thioredoxin system in diabetic nephropathyAndrew Advani, Richard E Gilbert, Kerri Thai, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2025
Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonistWeier Qi, Simina M Boca, Alessandro Boianelli, et al.
Pageof 4